Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1101-1115

  Aziz, Natasha ^a   Cherwinski, Holly ^a   McMahon, Martin ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYCLIN D1; GENE PRODUCT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; ORNITHINE DECARBOXYLASE INHIBITOR; RAF PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; GENE EXPRESSION REGULATION; GENE INDUCTION; GROWTH REGULATION; MALIGNANT TRANSFORMATION; MITOGENESIS; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032951523     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.2.1101     Document Type: Article

References (138)

1. Abrahamsen, M. S., R. S. Li, W. Dietrich-Goetz, and D. R. Morris. 1992. Multiple DNA elements responsible for transcriptional regulation of the ornithine decarboxylase gene by protein kinase A. J. Biol. Chem. 267: 18866-18873.
2. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
3. Alberts, A. S., O. Geneste, and R. Treisman. 1998. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92:475-487.
4. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
5. Amati, B., and H. Land. 1994. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4:102-108.
6. Barone, M. V., and S. A. Courtneidge. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512.
7. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
8. Bennett, M. R., S. Anglin, J. R. McEwan, R. Jagoe, A. C. Newby, and G. I. Evan. 1994. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J. Clin. Investig. 93:820-828.
9. Bennett, M. R., G. I. Evan, and A. C. Newby. 1994. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ. Res. 74:525-536.
10. Birrer, M. J., S. Segal, J. S. De Greve, F. Kaye, E. A. Sausville, and J. D. Minna. 1988. L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol. Cell. Biol. 8:2568-2673.
11. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
12. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
13. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
14. Bosch, E., H. Cherwinski, D. Peterson, and M. McMahon. 1997. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 15:1021-1033.
15. Brabant, M., L. McConlogue, T. van Daalen Wetters, and P. Coffino. 1988. Mouse ornithine decarboxylase gene: cloning, structure, and expression. Proc. Natl. Acad. Sci. USA 85:2200-2204.
16. Collins, J. F., P. Herman, C. Schuch, and G. C. Bagby, Jr. 1992. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J. Clin. Investig. 89:1523-1527.
17. Colman, M. S., and M. C. Ostrowski. 1996. The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling. Nucleic Acids Res. 24:1971-1978.
18. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:330-341.
19. Courtneidge, S. A., R. Dhand, D. Pilat, G. M. Twamley, M. D. Waterfield, and M. F. Roussel. 1993. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J. 12:943-950.
20. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
21. D'Arcangelo, G., and S. Halegoua. 1993. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol. 13:3146-3155.
22. DeClue, J. E., K. Zhang, P. Redford, W. C. Vass, and D. R. Lowy. 1991. Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus. Mol. Cell. Biol. 11:2819-2825.
23. Dent, P., W. Haser, T. A. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
24. Dickson, B., F. Sprenger, D. Morrison, and E. Hafen. 1992. Raf functions downstream of Ras1 in the Sevenless signal transduction pathway. Nature 360:600-603.
25. Downward, J. 1997. Cell cycle: routine role for Ras. Curr. Biol. 7:R258-R260.
26. Downward, J. 1992. Regulation of p21ras by GTPase activating proteins and guanine nucleotide exchange proteins. Curr. Opin. Genet. Dev. 2:13-18.
27. Eisenman, R. N., and J. A. Cooper. 1995. Signal transduction. Beating a path to Myc. Nature 378:438-439.
28. Fabian, J. R., I. O. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
29. Fowles, L. F., M. L. Martin, L. Nelsen, K. J. Stacey, D. Redd, Y. M. Clark, Y. Nagamine, M. McMahon, D. A. Hume, and M. C. Ostrowski. 1998. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18:5148-5156.
30. Fumagalli, S., N. F. Totty, J. J. Hsuan, and S. A. Courtneidge. 1994. A target for Src in mitosis. Nature 368:871-874.
31. Garte, S. J. 1993. The c-myc oncogene in tumor progression. Crit. Rev. Oncog. 4:435-449.
32. Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers. 1995. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14:1508-1519.
33. Gomez, N., and P. Cohen. 1991. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinase. Nature 353:170-173.
34. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
35. 2-terminal activation domain of c-Myc. FEBS Lett. 353:281-285.
36. Hall, M., and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-108.
37. Han, M., A. Golden, Y. Han, and P. W. Sternberg. 1993. C elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature 363: 133-140.
38. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
39. Heby, O., and L. Persson. 1990. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem. Sci. 15:153-158.
40. Holtta, E., L. Sistonen, and K. Alitalo. 1988. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J. Biol. Chem. 263:4500-4507.
41. Howe, L. R., and C. J. Marshall. 1993. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J. Biol. Chem. 268:20717-20720.
42. Hurta, R. A., A. Huang, and J. A. Wright. 1996. Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells. J. Cell. Biochem. 60:572-583.
43. Johnson, L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R. T. Bronson, H. Umanoff, W. Edelmann, R. Kucherlapati, and T. Jacks. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:2468-2481.
44. Johnston, J. M., and W. L. Carroll. 1992. c-myc hypermutation in Burkitt's lymphoma. Leuk. Lymphoma 8:431-439.
45. Joneson, T., and D. Bar-Sagi. 1997. Ras effectors and their role in mitogenesis and oncogenesis. J. Mol. Med. 75:587-593.
46. Kaplan, J. M., G. Mardon, J. M. Bishop, and H. E. Varmus. 1988. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant. Mol. Cell. Biol. 8:2435-2441.
47. Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:75-79.
48. Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603-610.
49. Kerkhoff, E., R. Houben, S. Loffler, J. Troppmair, J. E. Lee, and U. R. Rapp. 1998. Regulation of c-myc expression by Ras/Raf signalling. Oncogene 16:211-6.
50. Khosravi-Far, R., and C. J. Der. 1994. The Ras signal transduction pathway. Cancer Metastasis Rev. 13:67-89.
51. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426-428.
52. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
53. Kumar, A. P., P. K. Mar, B. Zhao, R. L. Montgomery, D. C. Kang, and A. P. Butler. 1995. Regulation of rat ornithine decarboxylase promoter activity by binding of transcription factor Sp1. J. Biol. Chem. 270:4341-4348.
54. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
55. Lahti, J. M., H. Li, and V. J. Kidd. 1997. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J. Biol. Chem. 272:10859-10869.
56. Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and M. C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355-5362.
57. Lavoie, J. N., G. L'Allemain, A. Brunet, R. Muller, and J. Pouyssegur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616.
58. Leonetti, C., I. D'Agnano, F. Lozupone, A. Valentini, T. Geiser, G. Zon, B. Calabretta, G. C. Citro, and G. Zupi. 1996. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. J. Natl. Cancer Inst. 88:419-429.
59. Li, M., H. Lonial, R. Citarella, D. Lindh, L. Colina, and R. Kramer. 1996. Tumor inhibitory activity of anti-ras ribozymes delivered by retroviral gene transfer. Cancer Gene Ther. 3:221-229.
60. Lloyd, A. C., H. F. Paterson, J. D. Morris, A. Hall, and C. J. Marshall. 1989. p21H-ras-induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C. EMBO J. 8:1099-1104.
61. Lu, X., T. B. Chou, N. G. Williams, T. Roberts, and N. Perrimon. 1993. Control of cell fate determination by p21ras/Ras1, an essential component of torso signaling in Drosophila. Genes Dev. 7:621-632.
62. Luttrell, D. K., L. M. Luttrell, and S. J. Parsons. 1988. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol. Cell. Biol. 8:497-501.
63. MacNicol, A. M., A. J. Muslin, and L. T. Williams. 1993. Raf-1 kinase is essential for early Xenopus development and mediates the induction of mesoderm by FGF. Cell 73:571-583.
64. Mangues, R., I. Seidman, A. Pellicer, and J. W. Gordon. 1990. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene. Oncogene 5:1491-1497.
65. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande-Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase. Science 265:966-970.
66. Marais, R., V. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136-3145.
67. Marais, R., V. Light, H. F. Paterson, C. S. Mason, and C. J. Marshall. 1997. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J. Biol. Chem. 272:4378-4383.
68. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
69. McCarthy, S. A., N. Aziz, and M. McMahon. 1997. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER. Methods Mol. Biol. 85:137-151.
70. McCarthy, S. A., D. Chen, B. S. Yang, J. J. Garcia Ramirez, H. Cherwinski, X. R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412.
71. McCarthy, S. A., M. L. Samuels, C. A. Pritchard, J. A. Abraham, and M. McMahon. 1995. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 9:1953-1964.
72. Mimori, K., M. Mori, T. Shiraishi, T. Fujie, K. Baba, H. Kusumoto, M. Haraguchi, H. Ueo, and T. Akiyoshi. 1997. Analysis of ornithine decarboxylase messenger ribonucleic acid expression in colorectal carcinoma. Dis. Colon Rectum 40:1095-1100.
73. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
74. Moriguchi, T., Y. Gotoh, and E. Nishida. 1996. Roles of the MAP kinase cascade in vertebrates. Adv. Pharmacol. 36:121-137.
75. Morrison, D. K., and R. E. Cutler. 1997. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9:174-179.
76. Moshier, J. A., D. L. Osborne, M. Skunca, J. Dosescu, J. D. Gilbert, M. C. Fitzgerald, G. Polidori, R. L. Wagner, S. J. Friezner Degen, G. D. Luk, et al. 1992. Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells. Nucleic Acids Res. 20:2581-2590.
77. Nass, S. J., and R. B. Dickson. 1997. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat. 44:1-22.
78. Nishida, E., and Y. Gotoh. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:128-131.
79. Nishida, Y., Y. H. Inoue, L. Tsuda, T. Adachi-Yamada, Y. M. Lim, M. Hata, H. Y. Ha, and S. Sugiyama. 1996. The Raf/MAP kinase cascade in cell cycle regulation and differentiation in Drosophila. Cell Struct. Funct. 21:437-444.
80. Nori, M., U. S. Vogel, J. B. Gibbs, and M. J. Weber. 1991. Inhibition of v-src-induced transformation by a GTPase-activating protein. Mol. Cell. Biol. 11:2812-2818.
81. Packham, G., and J. L. Cleveland. 1997. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene 15:1219-1232.
82. Palvimo, J. J., M. Partanen, and O. A. Janne. 1996. Characterization of cell-specific modulatory element in the murine ornithine decarboxylase promoter. Biochem. J. 316:993-998.
83. Parsons, J. T., and S. J. Parsons. 1997. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell Biol. 9:187-192.
84. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
85. Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186-189.
86. Price, M. A., C. Hill, and R. Treisman. 1996. Integration of growth factor signals at the c-fos serum response element. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:551-559.
87. Prins, J., E. G. De Vries, and N. H. Mulder. 1993. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Anticancer Res. 13:1373-1385.
88. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:6430-6442.
89. Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59-70.
90. Qureshi, S. A., M. Rim, J. Bruder, W. Kolch, U. Rapp, V. P. Sukhatme, and D. A. Foster. 1991. An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter. J. Biol. Chem. 266:20594-20597.
91. Rapp, U. R., J. L. Cleveland, S. M. Storm, T. W. Beck, and M. Huleihel. 1986. Transformation by raf and myc oncogenes. Princess Takamatsu Symp. 17:55-74.
92. Robertson, L. M., T. K. Kerppola, M. Vendrell, D. Luk, R. J. Smeyne, C. Bocchiaro, J. I. Morgan, and T. Curran. 1995. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 14:241-252.
93. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180-186.
94. Roche, S., S. Fumagalli, and S. A. Courtneidge. 1995. Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science 269:1567-1569.
95. Roussel, M. F. 1997. Regulation of cell cycle entry and G1 progression by CSF-1. Mol. Reprod. Dev. 46:11-18.
96. Roussel, M. F., J. L. Cleveland, S. A. Shurtleff, and C. J. Sherr. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature 353:361-363.
97. Roussel, M. F., J. N. Davis, J. L. Cleveland, J. Ghysdael, and S. W. Hiebert. 1994. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9:405-415.
98. Roussel, M. F., and C. J. Sherr. 1989. Mouse NIH 3T3 cells expressing human colony-stimulating factor 1 (CSF-1) receptors overgrow in serum-free medium containing human CSF-1 as their only growth factor. Proc. Natl. Acad. Sci. USA 86:7924-7927.
99. Roussel, M. F., S. A. Shurtleff, J. R. Downing, and C. J. Sherr. 1990. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes. Proc. Natl. Acad. Sci. USA 87:6738-6742.
100. Roussel, M. F., A. M. Theodoras, M. Pagano, and C. J. Sherr. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92:6837-6841.
101. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
102. Sapi, E., M. B. Flick, S. Rodov, and B. M. Kacinski. 1998. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res. 58:1027-1033.
103. Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12:4181-4189.
104. Schaap, D., J. van der Wal, L. R. Howe, C. J. Marshall, and W. J. van Blitterswijk. 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:20232-20236.
105. Schwab, M. 1994. Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome 1p. Recent Results Cancer Res. 135:7-16.
106. Schwartz, R. C., L. W. Stanton, S. C. Riley, K. B. Marcu, and O. N. Witte. 1986. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol. Cell. Biol. 6:3221-3231.
107. 2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521-23524.
108. 1 cyclins and cell cycle progression. Proc. Assoc. Am. Physicians 107:181-186.
109. Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88.
110. Sklar, M. D., E. Thompson, M. J. Welsh, M. Liebert, J. Harney, H. B. Grossman, M. Smith, and E. V. Prochownik. 1991. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol. Cell. Biol. 11:3699-3710.
111. Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543.
112. Snow, E. C. 1997. The role of c-myc during normal B-cell proliferation, and as B cells undergo malignant transformation. Curr. Top. Microbiol. Immunol. 224:211-220.
113. Sternberg, P. W., and H. R. Horvitz. 1991. Signal transduction during C. elegans vulval induction. Trends Genet. 7:356-371.
114. Stokoe, D., and F. McCormick. 1997. Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro. EMBO J. 16:2384-2396.
115. Storm, S. M., U. Brennscheidt, G. Sithanandam, and U. R. Rapp. 1990. raf oncogenes in carcinogenesis. Crit. Rev. Oncog. 2:1-8.
116. Takahashi, F., S. Endo, T. Kojima, and K. Saigo. 1996. Regulation of cell-cell contacts in developing Drosophila eyes by Dsrc41, a new, close relative of vertebrate c-src. Genes Dev. 10:1645-1656.
117. Terada, K., Y. Kaziro, and T. Satoh. 1995. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. J. Biol. Chem. 270:27880-27886.
118. Thomas, S. M., and J. S. Brugge. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13:513-604.
119. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
120. Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:96-101.
121. Troppmair, J., and U. R. Rapp. 1997. Apoptosis regulation by Raf, Bcl-2, and R-Ras. Recent Results Cancer Res. 143:245-249.
122. Twamley-Stein, G. M., R. Pepperkok, W. Ansorge, and S. A. Courtneidge. 1993. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90:7696-7700.
123. Umbhauer, M., C. J. Marshall, C. S. Mason, R. W. Old, and J. C. Smith. 1995. Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376:58-62.
124. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
125. Warne, P. H., P. R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:352-355.
126. Williams, N. G., and T. M. Roberts. 1994. Signal transduction pathways involving the Raf proto-oncogene. Cancer Metastasis Rev. 13:105-116.
127. Williams, N. G., T. M. Roberts, and P. Li. 1992. Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase. Poc. Natl. Acad. Sci. USA 89:2922-2926.
128. Williams, S. A., E. R. Gillan, E. Knoppel, J. S. Buzby, Y. Suen, and M. S. Cairo. 1997. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma. Ann. Oncol. 8(Suppl.):25-30.
129. Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cipl. Mol. Cell. Biol. 17:5598-5611.
130. Wrighton, C., and M. Busslinger. 1993. Direct transcriptional stimulation of the ornithine decarboxylasc gene by Fos in PC12 cells but not in fibroblasts. Mol. Cell. Biol. 13:4657-4669.
131. Xia, K., N. K. Mukhopadhyay, R. C. Inhorn, D. L. Barber, P. E. Rose, R. S. Lee, R. P. Narsimhan, A. D. D'Andrea, J. D. Griffin, and T. M. Roberts. 1996. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc. Natl. Acad. Sci. USA 93:11681-11686.
132. Xie, W., and H. R. Herschman. 1995. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J. Biol. Them. 270:27622-27628.
133. Yamauchi, N., A. A. Kiessling, and G. M. Cooper. 1994. The Ras/Raf signaling pathway is required for progression of mouse embryos through the two-cell stage. Mol. Cell. Biol. 14:6655-6662.
134. Yancopoulos, G. D., P. D. Nisen, A. Tesfaye, N. E. Kohl, M. P. Goldfarb, and F. W. Alt. 1985. N-myc can cooperate with ras to transform normal cells in culture. Proc. Natl. Acad. Sci. USA 82:5455-5459.
135. Yang, B. S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.
136. Yao, B., Y. Zhang, S. Delikat, S. Mathias, S. Basu, and R. Kolesnick. 1995. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310.
137. Zornig, M., and G. I. Evan. 1996. Cell cycle: on target with Myc. Curr. Biol. 6:1553-1556.
138. Zou, X., S. Rudchenko, K. Wong, and K. Calame. 1997. Induction of c-myc transcription by the v-Ab1 lyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654-662.